Publications by authors named "Sandy Amorim"

Claim this Profile
L
Large B-cell lymphoma: The LYSA pragmatic guidelines.
Pierre Sesques, Guillaume Manson, Sydney Dubois, Francois Xavier Gros, Gabriel Brisou, Sandy Amorim

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary mediastinal B-cell lymphoma (PMBCL): The LYSA pragmatic guidelines.
Loïc Renaud, Marie Donzel, Justine Decroocq, Pierre Decazes, Jean Galtier, Sandy Amorim

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Sylvain Carras, Alexia Torroja, Anouk Emadali, Emilie Montaut, Nicolas Daguindau, Sandy Amorim

Haematologica· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Hervé Ghesquières, Fanny Cherblanc, Aurélien Belot, Sophie Micon, Krimo K Bouabdallah, Sandy Amorim

Blood Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group.
Raphaelle Aubrais, Krimo Bouabdallah, Loic Chartier, Charles Herbaux, Anne Banos, Sandy Amorim

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP.
Julia Driessen, Marie José Kersten, Lydia Visser, Anke van den Berg, Sanne H Tonino, Sandy Amorim

Leukemia· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort.
Florian Bouclet, Anne Calleja, Marie-Sarah Dilhuydy, Lauren Véronèse, Bruno Pereira, Sandy Amorim

Ann Hematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients.
Benoit Milcent, Nathalie Josseaume, Quentin Riller, Ilenia Giglioli, Emilia Rabia, Sandy Amorim

Cancer Immunol Immunother· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Jérôme Cornillon, Elisabeth Daguenet, Jacques-Olivier Bay, Adrien Chauchet, Gilles Salles, Sandy Amorim

Ann Hematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive care unit admission in patients with T cell lymphomas: clinical features and outcome.
Guillaume Dumas, Lucie Biard, Claire Givel, Sandy Amorim, Lara Zafrani

Ann Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
Emilio Iannitto, Monica Bellei, Sandy Amorim, Andrés J M Ferreri, Luigi Marcheselli

Br J Haematol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Laurent Gilardin, Sandy Amorim, Sophie Bernard, Odonchimeg Ravdan, Catherine Thieblemont

Bull Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study.
Benedicte Deau, Sandy Amorim, Aurore Perrot, Philippe Quittet, Jerome Cornillon

Br J Haematol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?
Camille Bigenwald, Stéphanie Harel, Florian Chevignon, Damien Roos-Weil, Olivier A Bernard, Sandy Amorim

Br J Haematol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of molecular techniques to diagnose Ureaplasma urealyticum and Nocardia farcinica pleuropneumonia in a patient with diffuse large B-cell lymphoma.
Etienne Canouï, Kim Blanc, Julien Loubinoux, Sandrine Valade, Cécile Hamard, Sandy Amorim

Int J Infect Dis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study.
Alexandre Morel, Josette Brière, Laurence Lamant, Michaël Loschi, Corinne Haioun, Sandy Amorim

Eur J Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab-ABV(D) for patients with Nodular lymphocyte predominant Hodgkin lymphoma ineligible for radiation therapy.
Sylvain Garciaz, Stephanie Harel, Sandy Amorim, Réda Bouabdallah, Catherine Thieblemont

Br J Haematol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment.
Sandy Amorim, Isabelle Fleury, Nicolas Mounier, Stéphanie Harel, Pauline Brice

Leuk Lymphoma· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does bendamustine impact the mobilization of peripheral blood stem cells? A multicenter retrospective study of 23 cases.
Anne-Claire Gac, Nabih Azar, Etienne Daguindau, Guillaume Cartron, Luc M Fornecker, Sandy Amorim

Leuk Lymphoma· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study.
Sandy Amorim, Anastasios Stathis, Mary Gleeson, Sunil Iyengar, Valeria Magarotto

Lancet Haematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of ibrutinib in the treatment of Bing-Neel syndrome.
Aurélie Cabannes-Hamy, Richard Lemal, Lauriane Goldwirt, Stéphanie Poulain, Sandy Amorim

Am J Hematol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis.
Alexandre Alanio, Blandine Denis, Samia Hamane, Emmanuel Raffoux, Régis Peffault de Latour, Sandy Amorim

Emerg Infect Dis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse.
Sophie Bernard, Lauriane Goldwirt, Sandy Amorim, Pauline Brice, Josette Brière

Blood· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Yield and Safety of Computed Tomography-guided Mediastinal Core Needle Biopsies.
Constance de Margerie-Mellon, Cédric de Bazelaire, Sandy Amorim, Pauline Brice, Abdellatif Tazi

J Thorac Imaging· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study.
Jehan Dupuis, Franck Morschhauser, Hervé Ghesquières, Hervé Tilly, Olivier Casasnovas, Sandy Amorim

Lancet Haematol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis